MNOV vs TECH · rev $123.3K vs P/E 65, rev $1.22B
MediciNova Inc (MNOV) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
MediciNova Inc (MNOV) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MNOV revenue for 2025-09-30 was $123.3K. Net income was -$9.2M. Revenue was down 8.4% from 2025-06-30 to 2025-09-30. MNOV currently screens at market cap $66.0M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MNOV currently screens at market cap $66.0M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MNOV and TECH stock pages for the full models.
Not investment advice.